Financial

The company applies machine-learning analytic tools to transform structured and unstructured data, along with external data sources, into actionable insights.

The money was provided by existing investors Cowboy Ventures and Floodgate, bringing the company's total funding to at least $3.3 million.

The free service will still include community support, whereas those opting to pay for a mentor will get a more personal guidance to achieve their goals.

The company offers a secure, HIPAA-compliant platform that gives consumers direct access to their choice of U.S. board-certified clinicians.

The plan is to use the funds to facilitate the expansion of sales, marketing, project management and implementation resources in the North American market.

Cherubic Ventures led the round with participation from Yuan-jin Capital, Sino Strategy, Alan Chien and Ming-zhe Ou, the former general manager of Lenovo Taiwan.

The investment will be used to help the company quickly scale production, recruit top tier talent, expand marketing activities and the product line.

Initially, the company worked with clinical trials exclusively, but has later branched out to ongoing disease management programs with healthcare providers.

The company plans to use the fresh capital to accelerate growth through physician-led implementation, and build out its sales and marketing teams.

The Series A1 funding round was led by UK-based Eurovestech, with participation from Peak Ventures, and a number of angel investors.